Intervention

Tezepelumab

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 31 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials31
Recruiting7
Common conditions25
Lead sponsors shown12
Advertisement

Clinical trials

31 shown
Physical Activity Promotion and Clinical Remission in Severe AsthmaNCT07735494 · 2026-07-31
RECRUITING
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)NCT06705764 · 2026-05-11
RECRUITING
Phase 3b Study in Patients With Severe Asthma Treated With TezepelumabNCT07363642 · 2026-01-28
RECRUITING
Tezspire Cardiac Events PASSNCT06951867 · 2025-09-15
RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)NCT06878261 · 2025-03-25
RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)NCT06883305 · 2025-03-18
RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaNCT06023589 · 2023-08-24
RECRUITING
Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary AspergillosisNCT07757841 · 2026-09-01
NOT_YET_RECRUITING
Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal PolypsNCT07046117 · 2025-10-01
NOT_YET_RECRUITING
Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With TezepelumabNCT07013123 · 2025-07-15
NOT_YET_RECRUITING
Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in ItalyNCT06948396 · 2025-06-25
ACTIVE_NOT_RECRUITING
Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe AsthmaNCT06740045 · 2025-01-01
NOT_YET_RECRUITING
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.NCT06473779 · 2024-09-30
ACTIVE_NOT_RECRUITING
Tezepelumab Treatment in Korean Severe Asthma PatientsNCT06438913 · 2024-06-12
NOT_YET_RECRUITING
Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma CentresNCT06455462 · 2024-04-22
COMPLETED
Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)NCT06189742 · 2024-01-29
ACTIVE_NOT_RECRUITING
Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic AsthmaNCT05740748 · 2023-04-01
UNKNOWN
REVErsing Airway Remodelling With TezepelumabNCT05651841 · 2023-03-27
COMPLETED
Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe AsthmaNCT05280418 · 2022-11-08
COMPLETED
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPDNCT05507242 · 2022-10-25
UNKNOWN
Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaNCT05398263 · 2022-08-09
TERMINATED
Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe AsthmaNCT05274815 · 2022-05-17
COMPLETED
Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United StatesNCT05329194 · 2022-04-29
COMPLETED
Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With AsthmaNCT05062759 · 2021-08-23
COMPLETED
Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With AsthmaNCT04673630 · 2021-02-23
COMPLETED
Tezepelumab COPD Exacerbation StudyNCT04039113 · 2019-07-30
COMPLETED
A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult SubjectsNCT03989544 · 2019-06-19
COMPLETED
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled AsthmaNCT03706079 · 2019-01-07
COMPLETED
Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)NCT03688074 · 2018-11-02
COMPLETED
Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaNCT03406078 · 2018-03-05
COMPLETED
Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic AsthmaNCT01405963 · 2011-10-31
COMPLETED

Common conditions

Trial status mix

COMPLETED13
RECRUITING7
NOT_YET_RECRUITING5
ACTIVE_NOT_RECRUITING3
UNKNOWN2
TERMINATED1

Phase mix

PHASE314
PHASE25
NA3
PHASE13
PHASE42
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.